NASDAQ:SGMT | Free Cash Flow | Sagimet Biosciences Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$8.61M
2025-12-31-$11.83M
2025-03-31-$14.54M
2024-12-31-$11.02M
2024-03-31-$6.21M
2023-12-31-$7.08M
2023-03-31-$7.08M
2022-12-31-$7.45M
2022-03-31-$10.8M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$45.65M
2024-12-31-$42.44M
2023-12-31-$23.77M
2022-12-31-$24.49M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.